KAHIRA PHARMACEUTICALS & CHEMICAL INDUSTRIES COMPANY

Kahira Pharmaceuticals & Chemical Industries Company

CPCI

EGS38391C016

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
63.87 ^EGP	-.--%		-9.06%	+12.94%

2023	Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the First Quarter Ended September 30, 2023	CI
2023	Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2023	CI

Cairo Pharmaceuticals Announces Reviewed Earnings Results for the Nine Months Ended September 30, 2018

November 13, 2018

Cairo Pharmaceuticals announced reviewed earnings results for the nine months ended September 30, 2018. For the period, the company reported net profit of EGP 31,242,715 compared to EGP 25,606,877.

Latest news about Kahira Pharmaceuticals & Chemical Industries Company

Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the First Quarter Ended September 30, 2023	Dec. 11	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2023	23-10-09	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Nine Months Ended March 31, 2023	23-05-23	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-21	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Third Quarter Ended March 31, 2022	22-05-24	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Third Quarter Ended March 31, 2022	22-05-24	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-14	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the First Quarter Ended September 30, 2021	21-11-13	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2021	21-09-08	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Nine Months Ended March 31, 2021	21-06-10	CI
Cairo Pharmaceuticals Announces Audited Earnings Results for the Six Months Ended December 31, 2020	21-02-15	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Unaudited Earnings Results for the First Half of Fiscal Year 2020	20-02-10	CI
Kahira Pharmaceuticals Reports Earnings Results for the Fiscal Year 2019	19-09-29	CI
Cairo Pharmaceuticals Announces Audited Earnings Results for the Nine Months Ended March 31, 2019	19-05-14	CI
Cairo Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2018	19-02-16	CI
Cairo Pharmaceuticals Announces Reviewed Earnings Results for the Nine Months Ended September 30, 2018	18-11-13	CI
Cairo Pharmaceuticals Declares Cash Dividend Payable on October 28, 2018	18-10-09	CI
Cairo Pharmaceuticals Reports Earnings Audited Results for the Year Ended June 30, 2018	18-08-29	CI
Cairo Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2017	18-02-11	CI
Cairo Pharmaceuticals Announces Earnings Results for the First Quarter Ended on September 30, 2017	17-11-14	CI
Cairo Pharmaceuticals Declares Cash Dividends, Payable on October 26, 2017	17-10-07	CI
Cairo Pharmaceuticals Announces Audited Earnings Results for the Year Ended on June 30, 2017	17-09-09	CI
Kahira Pharmaceuticals & Chemical Industries Company Announces Earnings Results for the Nine Months Ended March 31, 2017	17-05-14	CI
Cairo Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2016	17-02-14	CI
Kahira Pharmaceuticals & Chemical Industries Co Reports Earnings Results for the First Half of Fiscal 2015	15-01-29	CI

Chart Kahira Pharmaceuticals & Chemical Industries Company

Duration

Period

Chart Kahira Pharmaceuticals & Chemical Industries Company

More charts

Cairo Pharmaceuticals specializes in manufacturing and marketing pharmaceutical products for the treatment of inflammatory, infectious, pulmonary, parasitic, dermatological, cardiovascular, allergic diseases, etc. The group also provides veterinary products.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
KAHIRA PHARMACEUTICALS & CHEMICAL INDUSTRIES COMPANY	+12.94%	19.93M
ELI LILLY AND COMPANY	+34.00%	664B
NOVO NORDISK A/S	+29.29%	567B
JOHNSON & JOHNSON	-7.75%	354B
MERCK & CO., INC.	+18.53%	330B
ABBVIE INC.	+4.95%	286B
ASTRAZENECA PLC	+13.79%	234B
NOVARTIS AG	+4.93%	199B
ROCHE HOLDING AG	-9.78%	196B
AMGEN INC.	-4.89%	148B